Beauty Health (SKIN) Set to Announce Earnings on Thursday

Beauty Health (NASDAQ:SKIN) is anticipated to announce its Q3 2026 results after the market closes on Thursday, November 5th. Analysts expect Beauty Health to post earnings of ($1.3350) per share and revenue of $67.97 million for the quarter. Interested persons can check the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Thursday, November 5, 2026 at 4:30 PM ET.

Beauty Health (NASDAQ:SKIN) last posted its earnings results on Thursday, August 6th. The company reported ($0.40) EPS for the quarter, beating analysts’ consensus estimates of ($0.50) by $0.10. Beauty Health had a negative return on equity of 47.83% and a negative net margin of 9.79%. The firm had revenue of $72.11 million during the quarter, compared to the consensus estimate of $74.45 million. On average, analysts expect Beauty Health to post ($3.18) EPS for the current fiscal year and ($1.16) EPS for the next fiscal year.

Beauty Health Trading Up 3.7%

SKIN stock opened at $10.49 on Thursday. The firm has a fifty day moving average price of $12.57 and a 200 day moving average price of $17.04. Beauty Health has a fifty-two week low of $9.89 and a fifty-two week high of $34.80. The company has a debt-to-equity ratio of 4.36, a quick ratio of 1.48 and a current ratio of 1.76. The firm has a market cap of $68.26 million, a PE ratio of -2.38 and a beta of 1.05.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the stock. Citigroup reaffirmed a “hold” rating on shares of Beauty Health in a research note on Thursday, October 15th. Stifel Nicolaus set a $10.00 price objective on shares of Beauty Health in a research note on Thursday, October 15th. Canaccord Genuity Group set a $11.00 price objective on shares of Beauty Health and gave the stock a “hold” rating in a research note on Thursday, October 22nd. Jefferies Financial Group restated a “hold” rating and issued a $11.00 target price (up from $0.85) on shares of Beauty Health in a report on Monday, October 19th. Finally, Zacks Research cut shares of Beauty Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 20th. One equities research analyst has rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Beauty Health has an average rating of “Hold” and an average price target of $18.00.

Beauty Health Company Profile

BeautyHealth is a global health and beauty company focused on providing technology, products and services for aesthetic and skincare businesses. Its flagship brand, HydraFacial, offers a non-invasive treatment platform that combines cleansing, exfoliation, extraction and hydration, with treatments delivered through proprietary devices and consumable solutions.

The company also provides professional skincare products, treatment systems and related solutions designed for use by physicians, dermatologists, aestheticians and other licensed practitioners.